Categories: All postsCannabis

HEXO is not a buy and hold stock, Keith Richards says

Keith Richards
Like many cannabis stocks, HEXO (HEXO Stock Quote, Chart TSX, NYSE:HEXO) hit its high back in October when the lead-up to legalization caused a pot stock frenzy.

Since then, the sector has had both a downturn and then another upturn since the start of January. Now with a new listing on the New York Stock Exchange and its joint venture agreement with Molson Coors Canada, is Hexo ready to hit that $9.00 high again? Maybe, says technical analyst and portfolio manager Keith Richards, but don’t expect the stock to go much higher.

HEXO’s chart looks a little different from the other major players in Canadian cannabis, in that where December 2017 and January 2018 saw a significant spike across the sector, followed by a downturn over February and onward, HEXO definitely rose in December, 2017, but then refused to fall back: standing at $2.50 on December 1, 2017, the stock climbed to the high $3.00 range by late December and then hit the high $4.00 range by May, 2018.

Then, in mid-August all hell broke loose in the sector and HEXO rocketed to a high of $9.29 by October 16 — only to lose almost half of its value again over the following week.

But the stock is on the rise again, having climbed a whopping 68 per cent since the start of January to where it currently trades in the high $7.00 range. Is there more in tank? Richards says that getting back to $9.00 is a real possibility but that the stock will hit a lot of resistance once it gets there.

______________________________________________________________________________

Meet George. George is about to lose all his money on a stock tip from a stranger. Don’t be like George. Get picks from the pros at Cantech Letter.

Click here to sign up for free now.

_______________________________________________________________________________

“Whenever you get a stock that increases its liquidity for whatever reason —which might be a listing on another exchange— that’s a good thing,” says Richards of ValueTrend Wealth, to BNN Bloomberg on Friday. “Looking at the chart, this is definitely not a buy-and-hold stock, you really have to be trading it. You can see that it’s kind of on an upswing in a cycle again. It’s got a good possibility of reaching its [previous high].”

“Remember, all that technical resistance is is that somebody bought, in fact a whole bunch of people bought that stock at $9, and so as soon as you get back to $9, those people are going to say, ‘Man, do I ever want my money back,’” he says.

“And that’s literally how resistance works. Somebody bought it [at $9] and now they’re really sorry as they watched it fall to $4 and they’re just trying to break even. You’re going to hit that wall and you need a reason to get through the wall, so I would definitely be selling it at around $9, personally,” he says.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: hexo
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

12 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

23 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

2 days ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago